CAS: 596-43-0; Triphenylmethyl Bromide

该化合物是有机化合物,其特征为三重基(三苯甲基组),与溴原子结合,似乎是白色的,黄色的晶状固体,在正常条件下因其稳定性而闻名.三重溴主要用作有机合成的试剂,特别是保护酒精和胺,用来形成三重醚或可轻易保护的胺.该化合物相对而言是非极化的,在二氯甲烷和乙醚等有机溶剂中溶解,但在水中溶解.重要的是要小心处理三重溴,因为它可以是皮肤和眼刺激物,并应采取适当的安全措施避免吸入或摄入.此外,它对于水分很敏感,应储存在干燥的环境中,以保持其完整性和再活性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号519-73-3 三苯基甲烷 | CAS号19112-42-6 1,1,2,2-tetraph... | CAS号76-84-6 三苯基甲醇 | CAS号506-96-7 乙酰溴 | CAS号596-31-6 甲氧基三苯基甲烷 | CAS号968-39-8 乙基三苯甲基醚 | CAS号341-02-6 三苯基甲基四氟硼酸盐 | CAS号71-43-2 苯 | CAS号50653-07-1 triphenylmethyl... | CAS号105589-77-3 Tr-PEG2-OH | CAS号519-73-3 三苯基甲烷 | CAS号107-26-6 ethylmercury bromide | CAS号32926-43-5 N-B°C-N'-三苯甲基-L-组氨酸 | CAS号76-84-6 三苯基甲醇 | CAS号28859-82-7 bromo(2-methylp... | CAS号78504-78-6 ((isobutylperox... | CAS号596-30-5 Peroxide,bis(tr...

合成工艺路线路线简述

    📜三苯基甲醇置于氢溴酸体系中,用 乙酸酐 作为反应溶剂,化学反应生成 三苯基甲基溴
    参考文献:氟作为检测反应机理的标记
    标题:氟作为检测反应机理的标记
    摘要:在非极性溶剂中以下芳基自由基反应生成剂的热分解过程中,通过亲核活化的氟瞬态离子对的形成得到了证明:对氟苯基偶氮三苯基甲烷,对氟苯基重氮哌啶子,对氟苯基重氮氨基苯和对氟苯基肼.用对氟苯甲酰过氧化物获得阴性结果.
    DOI:10.1016/s0040-4020(01)99185-9

    海关参考信息

    专利信息


    专利号:US-9643915-B2
    优先权日:2013-03-15
    标题:Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
    发明人:ONICIU DANIELA CARMEN; HECKHOFF STEFAN; OSWALD BENOIT; REBMANN PETER; PEER ANDREAS; GONZALEZ MIGUEL; SAUTER PATRIK
    权利人:CERENIS THERAPEUTICS HOLDING SA
    摘要:The present invention includes methods for the synthesis of sphingomyelins and dihydrosphingomyelins. The present invention also includes methods for the synthesis of sphingosines and dihydrosphingosines. The present invention further includes methods for the synthesis of ceramides and dihydroceramides.

    专利号:US-8933181-B2
    优先权日:2006-10-06
    标题:Branched polymers and methods for their synthesis and use
    发明人:MOURI HIROSHI; LUO STEVEN; KURASCH JESSICA; ROBERTSON CHRISTOPHER G; WARREN SANDRA
    权利人:MOURI HIROSHI; LUO STEVEN; KURASCH JESSICA; ROBERTSON CHRISTOPHER G; WARREN SANDRA; BRIDGESTONE CORP
    摘要:Branched polymers including multi-branched polymers, functionalized branched polymers, star-branched polymers, and dendigraft polymers. Methods for the synthesis of branched polymers and method for the use of branched polymers in tire components are also included.

    专利号:US-4331688-A
    优先权日:1978-02-23
    标题 :Therapeutic method for inhibiting gastric secretion by administration of 15-deoxy-16-hydroxy prostaglandins
    发明人:KLUENDER HAROLD C; WOESSNER WARREN D; BIDDLECOM WILLIAM G
    权利人:MILES LAB
    摘要:Analogues of PGE 1 having the structural formula, ##STR1## in which J is R-hydroxymethylene or S-hydroxymethylene; R 1 is hydrogen; R 2 is hydrogen or together with R 4 is a methylene chain of 2 to 3 carbon atoms such that a cycloalkyl of 5 to 6 carbon atoms inclusive is formed; R 3 is hydrogen or methyl, or together with R 4 is a methylene or a lower alkylated methylene chain of 2 to 5 carbon atoms such that a cycloalkyl or a lower alkylated cycloalkyl of 4 to 7 carbon atoms inclusive is formed, or together with R 4 is bicycloalkyl or bicycloalkenyl moiety having the formula: ##STR2## such that a bicycloalkyl or bicycloalkenyl compound is formed, wherein m and n are integers having a value from 0 to 3, p is an integer having a value from 0 to 4 and q is an integer having a value of from 1 to 4 and wherein the double bond of such bicycloalkenyl is in the m, n, p, or q bridge; R 4 is hydrogen or methyl or together with R 2 or R 3 forms a cycloalkyl or bicycloalkyl or bicycloalkenyl as defined above, or together with R 5 is a methylene chain of 3 to 5 carbon atoms such that a cycloalkyl of 4 to 6 carbon atoms inclusive is formed; R 5 is selected from the group consisting of hydrogen, straight-chain alkyl having from 1 to 3 carbon atoms or together with R 4 forms a cycloalkyl as defined above; and R 6 is hydrogen or straight-chain alkyl having from 1 to 3 carbon atoms are disclosed. n PGE 1 ester analogues of the above formula, limited to the structures wherein two of R 2 , R 3 R 4 and R 5 form a cycloalkyl, lower alkylated cycloalkyl, bicycloalkyl or bicycloalkenyl are also disclosed. n The prostaglandin analogues selectively produce bronchodilation and decrease gastric secretion in vivo. n Methods of preparing the analogues and starting materials required in the synthesis of the analogues are also disclosed.

    专利号:US-4132738-A
    优先权日:1978-02-23
    标 题:Preparation of 15-deoxy-16-hydroxyprostaglandins
    发明人:KLUENDER HAROLD C; WOESSNER WARREN D; BIDDLECOM WILLIAM G
    权利人:MILES LAB
    摘要:Analogues of PGE 1 having the structural formula, ##STR1## in which J is R-hydroxymethylene or S-hydroxymethylene; R 1 is hydrogen; R 2 is hydrogen or together with R 4 is a methylene chain of 2 to 3 carbon atoms such that a cycloalkyl of 5 to 6 carbon atoms inclusive is formed; R 3 is hydrogen or methyl, or together with R 4 is a methylene or a lower alkylated methylene chain of 2 to 5 carbon atoms such that a cycloalkyl or a lower alkylated cycloalkyl of 4 to 7 carbon atoms inclusive is formed, or together with R 4 is bicycloalkyl or bicycloalkenyl moiety having the formula: ##STR2## SUCH THAT A BICYCLOALKYL OR BICYCLOALKENYL COMPOUND IS FORMED, WHEREIN M AND N ARE INTEGERS HAVING A VALUE FROM 0 TO 3, P IS AN INTEGER HAVING A VALUE FROM 0 TO 4 AND Q IS AN INTEGER HAVING A VALUE OF FROM 1 TO 4 AND WHEREIN THE DOUBLE BOND OF SUCH BICYCLOALKENYL IS IN THE M, N, P, OR Q BRIDGE; R 4 is hydrogen or methyl or together with R 2 or R 3 forms a cycloalkyl or bicycloalkyl or bicycloalkenyl as defined above, or together with R 5 is a methylene chain of 3 to 5 carbon atoms such that a cycloalkyl of 4 to 6 carbon atoms inclusive is formed; R 5 is selected from the group consisting of hydrogen, straight-chain alkyl having from 1 to 3 carbon atoms or together with R 4 forms a cycloalkyl as defined above; and R 6 is hydrogen or straight-chain alkyl having from 1 to 3 carbon atoms are disclosed. n Pge 1 ester analogues of the above formula, limited to the structures wherein two of R 2 , R 3 R 4 and R 5 form a cycloalkyl, lower alkylated cycloalkyl, bicycloalkyl or bicycloalkenyl are also disclosed. n The prostaglandin analogues selectively produce bronchodilation and decrease gastric secretion in vivo. n Methods of preparing the analogues and starting materials required in the synthesis of the analogues are also disclosed.

    专利号:WO-2013046211-A1
    优先权日:2011-09-27
    标 题 :Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide and intermediates thereof
    发明人:MOHAN RAO DODDA; KRISHNA REDDY PINGILI; VENKAT REDDY BUTHUKURI
    权利人:SYMED LABS LTD; MOHAN RAO DODDA; KRISHNA REDDY PINGILI; VENKAT REDDY BUTHUKURI
    摘要:TThe present invention provides processes for the preparation of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide (I) and intermediates thereof. Also provides novel intermediates and their use in the synthesis of oxazolidine derivatives.

    专利号:US-6448449-B2
    优先权日:2000-04-21
    标题:Process for preparation of (R)-1- (aryloxy)propan-2-ol
    发明人:LARROW JAY FRANCIS
    权利人:RHODIA CHIREX INC
    摘要:A process for the preparation of (R)-1-(2,3-difluoro-6-nitrophenoxy)-propan-2-ol, which is a useful intermediate in the synthesis of the widely used antibiotic Levofloxacin is provided. A process for the preparation of (R)-1-(2,3-difluoro-6-nitrophenoxy)-2-trimethylsiloxypropane is also described. The process includes the ring opening of (R)-propylene oxide with 2,3-difluoro-6-nitrophenyl trimethylsilyl ether in the presence of an optically active Co(salen) catalyst. The trimethylsilyl group of the reactant is transferred to the product aryloxy alcohol, which serves to protect the secondary alcohol in situ. Upon isolation, the trimethylsilyl group is removed and the resulting regioisomeric mixture purified to yield the desired (R)-1-(2,3-difluoro-6-nitrophenoxy)-propan-2-ol in high purity and yield.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Salvatore Debonis, Et Al. Structure-Activity Relationship Of S-Trityl-L-Cysteine Analogues As Inhibitors Of The Human Mitotic Kinesin Eg5. J Med Chem. 2008 Mar 13;51(5):1115-25.

    合成参考文献


    摘要:U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals., NX#04015
    摘要:Kitching, W.; Glenn, M., Science of Synthesis, (2004) 3, 189.
    摘要:Spivey, A. C.; Diaper, C. M., Science of Synthesis, (2003) 5, 146.
    摘要:Chen, G., Science of Synthesis, (2005) 6, 94.
    摘要:Kitching, W.; Glenn, M., Science of Synthesis, (2004) 3, 271.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知